STOCK TITAN
  1. Home
  2. Sec-filings
  3. GLTO
  4. [EFFECT] Galecto, Inc. SEC Filing

[EFFECT] Galecto, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 23, 2025 4:01 P.M.
Form: S-3
CIK: 0001800315
Company Name: Galecto, Inc.
File Number: 333-292175

Source: View Original Filing on SEC EDGAR

Stock GLTO logo
Galecto Inc.

NASDAQ:GLTO

GLTO Rankings

#5713 Ranked by Market Cap
N/A Ranked by Dividends
#78 Top Gainer

GLTO Latest News

Dec 16, 2025
Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Nov 10, 2025
Galecto Announces Acquisition of Damora Therapeutics
Nov 6, 2025
Galecto Reports Third Quarter 2025 Operating and Financial Results
Nov 3, 2025
Galecto to Highlight GB3226 Program at ASH 2025
Aug 5, 2025
Galecto Reports Second Quarter 2025 Operating and Financial Results

GLTO Latest SEC Filings

Dec 16, 2025
[PRE 14A] Galecto, Inc. Preliminary Proxy Statement
Dec 16, 2025
[S-3] Galecto, Inc. Shelf Registration Statement
Nov 17, 2025
[Form 3] Galecto, Inc. Initial Statement of Beneficial Ownership
Nov 17, 2025
[Form 3] Galecto, Inc. Initial Statement of Beneficial Ownership
Nov 17, 2025
[Form 3] Galecto, Inc. Initial Statement of Beneficial Ownership

GLTO Stock Data

35.59M
1.54M
3.68%
12.25%
0.95%
Biotechnology
Pharmaceutical Preparations
Link
Denmark
BOSTON